When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AGN - Evolus' Jeuveau matches Botox in study; shares up 3% premarket
Allergan plc
Evolus (NASDAQ:EOLS) is up 3% premarket on light volume in reaction to its announcement of results from a Korea-based Phase 3 head-to-head study comparing Jeuveau (prabotulinumtoxinA-xvfs) to Allergan's (NYSE:AGN) Botox (onabotulinumtoxinA) for the treatment of frown lines. The data were just published in the journal Dermatologic Surgery.
More news on: Evolus, Inc., Allergan plc, AbbVie Inc., Healthcare stocks news, Stocks on the move,